论文信息 - Homozygosity mapping reveals founder SEC23B‐Y462C mutations in Indian congenital dyserythropoietic anemia type II

Homozygosity mapping reveals founder SEC23B‐Y462C mutations in Indian congenital dyserythropoietic anemia type II

F1P1 V F 8 6.2 8.8 390 2 LM 1:1 ND CDA II band 3 Y462C/Y462C F2P1 V M 9 5.5 12.5 384 <0.2 LM 1:4 ND CDA II band 3 Y462C/Y462C F3P1 V M 6 10.8 6.4 368 0.4 LM 1:2 POS CDA II band 3 Y462C/Y462C F4P1 V M < 1 7.5 4.1 311 2.5 LM, EM 1:5 ND CDA II band 3 Y462C/Y462C F4P2 V M < 1 7.1 4.1 282 3.3 LM, EM 1:3 ND ND Y462C/Y462C F5P1a V M 21 8.4 3.2 301 2.6 LM, EM 1:3 ND CDA II band 3 Y462C/Y462C F6P1a V F 16 9.1 4.1 288 2.9 LM, EM 1:3 ND CDA II band 3 Y462C/Y462C F7P1a V F 17 7.6 5.4 221 4.2 LM, EM 1:2 ND CDA II band 3 Y462C/Y462C F8P1 V M 7 7 5.9 243 2 LM, EM 1:3 ND ND Y462C/Y462C F9P1 V M 6 5.3 6.1 210 1.6 LM, EM 1:3 ND ND Y462C/Y462C F10P1 V F 2 10.7 11 279 1 LM, EM 1:2.5 POS ND Y462C/Y462C F11P1 V M 7 6.2 7.1 289 1.2 LM, EM 1:4 ND ND Y462C/Y462C F12P1 V M 5 3.7 12.1 276 2 LM 1:1 POS ND Y462C/Y462C F13P1 V F 10 8.2 10.2 588 2.8 LM 1:3 ND ND Y462C/Y462C F13P2 V M 26 9.8 8.3 243 3.4 LM 1:4 ND ND Y462C/Y462C F14P1 V F 14 6.8 2.4 157 1.8 LM 1:4 ND ND Y462C/Y462C F15P1 V F 9 7 13.5 200 0.5 LM 1:1.2 POS ND Y462C/Y462C F16P1 V/O M 1 6.5 5.7 271 ND LM ND ND ND Y462C/WT F17P1 V/O M 1 7 7.8 431 ND LM, EM 1:4.5 ND ND Y462C/WT F18P1 V M 2 7.6 18.8 290 6.5 LM, EM 1:1 ND ND ND F19P1 V M 13 10.9 8.1 256 0.4 LM, EM 1:2 POS ND ND F20P1 V F 1 6.5 11.3 285 4.5 LM, EM 1:1 POS ND ND F21P1 V M 5 7.8 10.8 559 2.8 LM 1:3.5 POS ND ND F22P1 V F 6 9.1 15.9 340 3.5 LM NA POS ND ND F23P1 O F 10 6.4 4.9 459 3 LM 1:2 POS CDA II band 3 WT/WT F24P1 O M 4 7.5 7.6 335 NA LM 1:2.5 ND CDA II band 3 WT/WT F24P2 O M 4 6.3 11.7 439 1.5 LM, EM 1:3.5 POS CDA II band 3 WT/WT F25P1 O F 4 6 4.4 330 NA LM, EM 1:4 POS CDA II band 3 WT/WT

[1] Achille Iolascon,et al. Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: Definition of clinical and molecular spectrum and identification of new diagnostic scores , 2014, American journal of hematology.

[2] A. Iolascon,et al. Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II , 2013, Blood cells, molecules & diseases.

[3] L. Luzzatto,et al. Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population , 2011, American journal of hematology.

[4] A. Berrebi,et al. E109K Is a SEC23B Founder Mutation among Israeli Moroccan Jewish Patients with Congenital Dyserythropoietic Anemia Type II , 2011, Acta Haematologica.

[5] V. Rao,et al. Population structure of Aggarwals of north India as revealed by molecular markers. , 2010, Genetic testing and molecular biomarkers.

[6] A. Zanella,et al. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene , 2009, Human mutation.

[7] U. Pannicke,et al. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II , 2009, Nature Genetics.

[8] W. Wood,et al. Advances in the understanding of the congenital dyserythropoietic anaemias , 2005, British journal of haematology.